Utilization of ruthenium complex as pharmacological strategy to revert and/or prev...
Use of ruthenium complex cis-[Ru (bpy) 2 (NO2) (NO)] (PF6) 2) to reverse and / or ...
Possible linkage of beta-adrenergic overstimulation to mineralocorticoid receptor ...
Effects of drugs activating the NO-cGMP pathway on the production of MMPs in cell ...
Evaluation of the action of pravastatin on eNOS coupling and nitric oxide producti...
Microparticles and endothelial function in patients with COVID-19: effects of brad...
Assessment of the NLRP3 inflamassome's pharmacological inhibition regarding the ge...